All Available Technologies
The invention is a composite system useful for indicating and preventing fatigue on essentially any metallic structure.
A multifunctional photovoltaic-battery (PVB) which represents a new-concept integrated PVB device as a novel power source for photoelectron conversion and energy storage within one single device.
Cervical cancer is one of the most common malignancies worldwide, yet it is clearly preventable by population screening. It has been reported that <5% of women in underdeveloped countries have ever had a Pap test. That is due to shortage of medical resources, shortage of pathologists and cytotechnologists and the limited public awareness regarding screening programs. Some believe that the disease has reached an epidemic proportion with huge human and economic impact that is requiring immediate, innovative practical solutions. Even with the hope of HPV vaccination and the current push for HPV testing as a primary screening method, Pap smear remains to be the best cancer screening method known to mankind. The invention is a new method of using automated cellblock (CB) preparations of liquid-based [ThinPrep + SurePath] and conventional samples to produce virtual slides.
A novel class of small molecule Alpha, Beta-ABAD interaction inhibitors for the treatment of Alzheimer's Disease.
This invention introduces carbon-biomaterial nanohybrids for use in high-performance, low-cost optoelectronic devices such as infrared detectors.
The current invention is a novel composition of matter that is comprised of a monomeric species, which could be used as co-initiator as well as co-monomer. Upon excitation using visible light, the monomeric species efficiently assists the photopolymerization and itself polymerizes into a material that is useful for dental applications.
A novel sensor design allows capture of angular fluid flow with greater accuracy than the conventional Pitot-type probe currently in use in commercial and military aircraft
A mechanical barrier system for reducing infections associated with intravascular catheters. The invention reduces the risk of bacterial contamination of the outer surface of the catheter at the skin entry site, which in turn prevents more serious infections caused by the spread of bacteria down the surface of the catheter into the bloodstream. The barrier device functions by forming an occlusive "boot" at the skin exit site and relies on use of a cyanoacrylate adhesive to complete the occlusive junction between the boot and the contaminated skin. At time of device removal, the device-adhesive bond is safely broken through a novel bladder release method, allowing for safe removal of the vascular catheter.